Max Financial Services (MFSL) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
12 May, 2026Executive summary
Revenue excluding investment income grew 17% YoY to ₹38,039 crore; consolidated PAT at ₹106 crore.
Individual adjusted first year premium rose 19% YoY to ₹9,885 crore, outpacing private industry growth.
Private market share expanded to 10.4% in FY'26, up 56 bps from FY'25.
Audited standalone and consolidated financial results for the year ended March 31, 2026, were approved, with unmodified opinions.
The group includes Axis Max Life Insurance Limited (AMLI), Max Life Pension Fund Management Limited, and Max Financial Employees Welfare Trust.
Financial highlights
Consolidated revenue from operations for FY26 was ₹47,674.11 crore, up from ₹46,468.91 crore in FY25.
Gross written premium grew 17% YoY to ₹38,877 crore.
Consolidated profit after tax for FY26 was ₹105.56 crore, down from ₹403.38 crore in FY25.
Embedded value (EV) at ₹28,871 crore, up 15% YoY.
Total assets (consolidated) as of March 31, 2026, stood at ₹1,98,935.56 crore.
Outlook and guidance
Focus remains on VNB growth through balanced product mix and higher business volumes.
Board approved an enabling resolution to raise up to ₹1,600 crore to meet funding requirements of AMLI.
Axis Bank subscribed to a further 6.02% equity in AMLI in April 2024, reducing the company’s stake to 80.98%.
Proposed amalgamation of the company with AMLI is underway, subject to regulatory and shareholder approvals.
Strategic push in protection, health, and annuity segments for long-term growth.
Latest events from Max Financial Services
- Standalone profit growth and core-business expansion contrasted with a Rs 154.39 crore consolidated loss.MFSL
Q4 01/02 - Consolidated profit included a Rs 427.63 crore Hutchison Essar disposal gain.MFSL
Q4 05/06 - Post-merger profit reached Rs. 180.62 lakhs as expansion plans met execution and licensing risks.MFSL
Q4 92/93 - FY95 profit rose as business units expanded and telecom ventures launched, alongside sizable commitments and exposures.MFSL
Q4 94/95 - FY94 profit reached Rs 775.53 lakh as pharma and BOPP growth strengthened operations.MFSL
Q4 93/94 - Revenue rose as investment-backed expansion broadened the business portfolio.MFSL
Q4 95/96 - Combined business volume grew, but lower profit and market pressures tempered FY97.MFSL
Q4 96/97 - Service-sector expansion advanced as lower investment income sharply reduced parent-level profit.MFSL
Q4 00/01 - Rs 37.20 crore PAT backed a pivot to healthcare, insurance and IT.MFSL
Q4 99/00 - A one-time telecom dividend lifted earnings as operating units improved and growth plans shifted to services.MFSL
Q4 98/99